Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease

Veselin Grozdanov (1) , Luc Bousset (2) , Meike Hoffmeister (3) , Corinna Bliederhaeuser (1) , Christoph Meier (4) , Karine Madiona (2) , Laura Pieri (2) , Martin Kiechle (1) , Pamela Mclean (5) , Jan Kassubek (1) , Christian Behrends (6) , Albert Ludolph (1) , Jochen H. Weishaupt (1) , Ronald Melki (2) , Karin Danzer (6)

1 University of Ulm, Department of Neurology, Ulm
2 LMN - Laboratoire des Maladies Neurodégénératives - UMR 9199
3 IBC2 - Institut für Biochemie II [Goethe-University Frankfurt am Main]
4 Institute of Organic Chemistry, University of Ulm, Ulm, Germany
5 Mayo Clinic [Jacksonville]
6 SyNergy - Munich Cluster for systems neurology [Munich]

Domains: Life Sciences [q-bio]; Neurons and Cognition [q-bio.NC]; Neurobiology

Veselin Grozdanov, Luc Bousset, Meike Hoffmeister, Corinna Bliederhaeuser, Christoph Meier, et al.. Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease. Annals of Neurology, 2019, ⟨10.1002/ana.25557⟩. ⟨cea-02279195⟩